Kodiak Sciences Inc (KOD) Stock Price, Quote & News

Company Profile

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degenerati...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 281 0850

Website: kodiak.com

Address:

1250 Page Mill Road, Palo Alto, United States

eganon69 Aug. 9 at 5:50 PM

$KOD LARGE C&H Breakout on W chart as well as smaller C&H breakout on D chart with $45.10 as Resistance now acting as Support. Friday was 2nd day close >$45.10. LARGE C&H TP = $88.41

0 · Reply

Merlintrader Aug. 7 at 2:50 PM

$KOD DAYBREAK Phase 3 topline data in wet AMD — expected September 2026 https://www.merlintrader.com/kodiak-sciences-stock-hub/

0 · Reply

DanFitz Aug. 7 at 12:52 AM

Here's your trade on Kodiak $KOD https://youtu.be/7jfj7zZpnSA

0 · Reply

Ecolispewy Aug. 6 at 9:33 PM

$KOD 13+ days to cover shorts out at these volumes and long conviction pushing.

0 · Reply

Ecolispewy Aug. 6 at 9:00 PM

$KOD need more volume

0 · Reply

RainyDayFund Aug. 6 at 8:58 PM

$KOD Go Baby!

0 · Reply

Stekli27 Aug. 6 at 4:32 PM

$KOD just waiting for the happy hour 🍻

0 · Reply

Cutlass Aug. 6 at 3:42 PM

$KOD Strong week unfolding, rather Perky too! ✍️👀🍒

0 · Reply

spinusn27 Aug. 6 at 3:31 PM

$KOD p

0 · Reply

droog_botski Aug. 6 at 3:25 PM

$KOD The question I have is at what price can they raise more capital ?

1 · Reply

Kodiak Sciences completes enrollment in first cohort of Phase 3 PEAK trial

Aug 6, 2026, 7:00 AM EDT - 4 days ago

Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026

2026-08-03T11:06:40.000Z - 7 days ago

Kodiak Sciences price target raised to $66 from $56 at JPMorgan

Jun 4, 2026, 11:40 AM EDT - 2 months ago

Kodiak Sciences Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 11:40 AM EDT - 2 months ago

Kodiak Sciences Slides: FY 2026

May 28, 2026, 6:09 PM EDT - 2 months ago

Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference

2026-05-11T16:59:46.000Z - 3 months ago

Kodiak Sciences upgraded to Buy from Neutral at Chardan

2026-05-07T21:46:34.000Z - 3 months ago

Kodiak Sciences reports Q1 EPS (94c), consensus ($1.01)

May 7, 2026, 4:00 PM EDT - 3 months ago

Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial Results

May 7, 2026, 4:00 PM EDT - 3 months ago

Kodiak Sciences Earnings release: Q1 2026

May 7, 2026, 4:00 PM EDT - 3 months ago

Kodiak Sciences Quarterly report: Q1 2026

May 1, 2026, 12:23 AM EDT - 3 months ago

Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences

Apr 22, 2026, 8:00 AM EDT - 3 months ago

Kodiak Sciences Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 3 months ago

Kodiak Sciences Proxy statement: Proxy filing

2026-04-02T16:07:19.000Z - 4 months ago

Kodiak Sciences falls -8.7%

2026-04-01T16:27:41.000Z - 4 months ago

Kodiak Sciences Stock (KOD) Rallies as Analysts Weigh In After Earnings

2026-04-01T15:15:17.000Z - 4 months ago

Kodiak Sciences reports Q4 EPS ($1.05) vs (84c) last year

2026-04-01T14:07:48.000Z - 4 months ago

Kodiak Sciences rises 10.7%

Mar 31, 2026, 4:45 PM EDT - 4 months ago

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results

Mar 31, 2026, 4:00 PM EDT - 4 months ago

Kodiak Sciences Annual report: Q4 2025

Mar 31, 2026, 4:00 PM EDT - 4 months ago

Kodiak Sciences Earnings release: Q4 2025

Mar 30, 2026, 10:00 AM EDT - 4 months ago

Kodiak Sciences: Road To $120

2026-03-27T13:29:25.000Z - 4 months ago

Kodiak Sciences price target raised to $80 from $50 at UBS

2026-03-27T10:05:12.000Z - 4 months ago

Kodiak Sciences price target raised to $58 from $38 at H.C. Wainwright

2026-03-26T18:10:55.000Z - 4 months ago

Kodiak Sciences price target raised to $56 from $39 at Jefferies

Mar 26, 2026, 12:33 PM EDT - 4 months ago

Kodiak Sciences stock soars over 60%: what's behind the sharp rally

2026-03-26T13:00:50.000Z - 4 months ago

Morning Movers: Kodiak Sciences skyrockets following GLOW2 study results

CMC CRBG DBI EQH LOVE MLKN NAVN

Mar 26, 2026, 8:12 AM EDT - 4 months ago

Kodiak Sciences shares surge after eye drug succeeds in late-stage study

2026-03-26T12:00:30.000Z - 4 months ago

Kodiak Sciences reports GLOW2 study of Zenkuda met primary endpoint

Mar 26, 2026, 6:00 AM EDT - 4 months ago

Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham

Mar 12, 2026, 7:00 AM EDT - 5 months ago

Kodiak Sciences Slides: Corporate presentation

Feb 4, 2026, 7:00 AM EST - 6 months ago

Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026

Jan 22, 2026, 10:26 AM EST - 7 months ago

These 20 stocks are strong choices for momentum investors

BE CELC COGT FBYD FRGE INBX LITE

2026-01-22T11:11:04.000Z - 7 months ago

Kodiak Sciences price target raised to $38 from $26 at H.C. Wainwright

Jan 12, 2026, 4:30 PM EST - 7 months ago

Kodiak Sciences Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 4:30 PM EST - 7 months ago

Kodiak Sciences Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 8:19 PM EST - 7 months ago

Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference

Dec 18, 2025, 8:26 PM EST - 8 months ago

Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares

Dec 16, 2025, 10:55 PM EST - 8 months ago

Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock

Dec 15, 2025, 4:01 PM EST - 8 months ago

Kodiak Sciences Announces Proposed Public Offering of Common Stock

Dec 3, 2025, 3:00 PM EST - 8 months ago

Kodiak Sciences Transcript: Evercore ISI 8th Annual HealthCONx Conference

Nov 17, 2025, 11:30 AM EST - 9 months ago

Kodiak Sciences Transcript: Jefferies London Healthcare Conference 2025

Nov 17, 2025, 11:30 AM EST - 9 months ago

Kodiak Sciences Slides: FY 2025

Nov 13, 2025, 4:05 PM EST - 9 months ago

Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2025 Financial Results

Nov 13, 2025, 4:00 PM EST - 9 months ago

Kodiak Sciences Earnings release: Q3 2025

Nov 13, 2025, 4:00 PM EST - 9 months ago

Kodiak Sciences Quarterly report: Q3 2025

Nov 12, 2025, 5:48 PM EST - 9 months ago

Kodiak Sciences to Present at Upcoming Investor Conferences

Nov 5, 2025, 7:00 AM EST - 9 months ago

Follow-up data for Kodiak's KSI-101 from the APEX study showed continued strengthening of clinical effect (≥90% of patients achieving absence of intraretinal and subretinal fluid) through week 20 in macular edema secondary to inflammation (MESI)

Oct 31, 2025, 12:01 PM EDT - 10 months ago

The Big 3: GOOGL, KOD, FTK

GOOG GOOGL FTK

Sep 15, 2025, 7:00 AM EDT - 11 months ago

New data for Kodiak's KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI)

Sep 2, 2025, 8:00 AM EDT - 1 year ago

Kodiak Sciences to Participate in Upcoming Scientific Conferences Highlighting KSI-101 in Patients with Macular Edema Secondary to Inflammation (MESI)

Aug 27, 2025, 10:40 AM EDT - 1 year ago

Harbour BioMed Reports 2025 Interim Results

Aug 19, 2025, 2:18 PM EDT - 1 year ago

Kodiak Sciences to Present at American Chemical Society Fall 2025

Aug 13, 2025, 4:00 PM EDT - 1 year ago

Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2025 Financial Results

Aug 13, 2025, 4:00 PM EDT - 1 year ago

Kodiak Sciences Quarterly report: Q2 2025

Aug 13, 2025, 4:00 PM EDT - 1 year ago

Kodiak Sciences Earnings release: Q2 2025

Jul 16, 2025, 1:00 PM EDT - 1 year ago

Kodiak Sciences Transcript: R&D Day 2025

Jul 16, 2025, 1:00 PM EDT - 1 year ago

Kodiak Sciences Slides: FY 2025

Jul 10, 2025, 8:00 AM EDT - 1 year ago

Kodiak Sciences to Host Investor R&D Day on July 16, 2025

Jun 25, 2025, 4:45 PM EDT - 1 year ago

Kodiak Sciences to Present KSI-101 Highlights at 2025 Congress of the International Ocular Inflammation Society

Jun 5, 2025, 9:20 AM EDT - 1 year ago

Kodiak Sciences Transcript: Jefferies Global Healthcare Conference 2025

May 29, 2025, 9:32 PM EDT - 1 year ago

Kodiak Sciences to Present at 2025 Jefferies Global Healthcare Conference

May 22, 2025, 4:00 PM EDT - 1 year ago

Kodiak Sciences Quarterly report: Q1 2025

May 22, 2025, 4:00 PM EDT - 1 year ago

Kodiak Sciences Earnings release: Q1 2025

May 14, 2025, 4:15 PM EDT - 1 year ago

Kodiak Sciences Announces Recent Business Highlights and First Quarter 2025 Financial Results

May 1, 2025, 11:43 PM EDT - 1 year ago

Kodiak Sciences Data at ARVO 2025 Highlight Power and Versatility of ABC Platform in Addressing Complex Multifactorial Ocular Diseases

Apr 22, 2025, 8:00 AM EDT - 1 year ago

Kodiak Sciences Proxy statement: Proxy Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

Kodiak Sciences Proxy statement: Proxy Filing

Mar 27, 2025, 4:01 PM EDT - 1 year ago

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

Mar 27, 2025, 10:30 AM EDT - 1 year ago

Kodiak Sciences Annual report: Q4 2024

Mar 27, 2025, 10:30 AM EDT - 1 year ago

Kodiak Sciences Earnings release: Q4 2024

Mar 10, 2025, 4:39 PM EDT - 1 year ago

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy

Feb 4, 2025, 7:30 AM EST - 1 year ago

Kodiak Sciences to Present at Glaucoma 360 New Horizons Forum 2025

Jan 15, 2025, 6:00 PM EST - 1 year ago

Kodiak Sciences Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 6:00 PM EST - 1 year ago

Kodiak Sciences Slides: FY 2025

Jan 7, 2025, 6:00 AM EST - 1 year ago

Kodiak Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

Dec 3, 2024, 2:35 PM EST - 1 year ago

Kodiak Sciences Transcript: 7th Annual Evercore ISI HealthCONx Conference

Nov 21, 2024, 4:00 AM EST - 1 year ago

Kodiak Sciences Transcript: Jefferies London Healthcare Conference 2024

Nov 14, 2024, 4:01 PM EST - 1 year ago

Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2024 Financial Results

Nov 14, 2024, 4:00 PM EST - 1 year ago

Kodiak Sciences Earnings release: Q3 2024

Nov 14, 2024, 4:00 PM EST - 1 year ago

Kodiak Sciences Quarterly report: Q3 2024

Nov 11, 2024, 6:15 AM EST - 1 year ago

Kodiak Sciences to Participate in Upcoming Investor Conferences

Oct 14, 2024, 5:35 PM EDT - 1 year ago

Kodiak Sciences to Present at Innovate Retina 2024

Sep 23, 2024, 10:30 AM EDT - 2 years ago

Kodiak Sciences Transcript: R&D Day 2024

Sep 23, 2024, 10:30 AM EDT - 2 years ago

Kodiak Sciences Slides: FY 2024

Sep 23, 2024, 6:00 AM EDT - 2 years ago

Kodiak Sciences to Host Investor R&D Day Today at 10:30am Eastern Time

Sep 17, 2024, 4:05 PM EDT - 2 years ago

Kodiak Sciences to Host Investor R&D Day on September 23, 2024 in New York City

Aug 14, 2024, 4:01 PM EDT - 2 years ago

Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results

Aug 14, 2024, 4:00 PM EDT - 2 years ago

Kodiak Sciences Quarterly report: Q2 2024

Aug 14, 2024, 4:00 PM EDT - 2 years ago

Kodiak Sciences Earnings release: Q2 2024

Jun 13, 2024, 8:00 AM EDT - 2 years ago

Kodiak Sciences Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

Jun 6, 2024, 8:00 AM EDT - 2 years ago

Kodiak Sciences Transcript: Jefferies 2024 Global Healthcare Conference

Jun 6, 2024, 8:00 AM EDT - 2 years ago

Kodiak Sciences Slides: FY 2024

May 29, 2024, 4:36 PM EDT - 2 years ago

Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences

May 15, 2024, 4:15 PM EDT - 2 years ago

Kodiak Sciences Quarterly report: Q1 2024

May 15, 2024, 4:15 PM EDT - 2 years ago

Kodiak Sciences Earnings release: Q1 2024

May 15, 2024, 4:01 PM EDT - 2 years ago

Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results

May 13, 2024, 7:32 PM EDT - 2 years ago

Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy

May 2, 2024, 4:30 PM EDT - 2 years ago

Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Kodiak Sciences Proxy statement: Proxy Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Kodiak Sciences Proxy statement: Proxy Filing

Mar 28, 2024, 4:30 PM EDT - 2 years ago

Kodiak Sciences Earnings Call Transcript: Q4 2023

Mar 28, 2024, 4:30 PM EDT - 2 years ago

Kodiak Sciences Annual report: Q4 2023

Mar 28, 2024, 4:30 PM EDT - 2 years ago

Kodiak Sciences Earnings release: Q4 2023

Mar 28, 2024, 4:30 PM EDT - 2 years ago

Kodiak Sciences Slides: Q4 2023

Mar 28, 2024, 6:30 AM EDT - 2 years ago

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Mar 26, 2024, 6:15 AM EDT - 2 years ago

Kodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024

Jan 30, 2024, 6:30 AM EST - 2 years ago

Kodiak Sciences Announces Upcoming Presentation of First Time Results of KSI-501ABC Phase 1 Study at the Angiogenesis, Exudation, and Degeneration 2024 Virtual Meeting

Jan 4, 2024, 4:15 PM EST - 2 years ago

Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Nov 21, 2023, 4:15 PM EST - 2 years ago

Kodiak Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference

Nov 14, 2023, 4:01 PM EST - 2 years ago

Kodiak Sciences Announces Third Quarter 2023 Financial Results and Recent Business Highlights

Nov 14, 2023, 7:00 AM EST - 2 years ago

Kodiak Sciences Quarterly report: Q3 2023

Nov 14, 2023, 7:00 AM EST - 2 years ago

Kodiak Sciences Earnings release: Q3 2023

Nov 6, 2023, 5:00 AM EST - 3 years ago

Kodiak reboots tarcocimab tedromer development program following strong positive results in Phase 3 diabetic retinopathy GLOW study and following dialogue with US regulatory authorities on a regulatory pathway for BLA submission

eganon69 Aug. 9 at 5:50 PM

$KOD LARGE C&H Breakout on W chart as well as smaller C&H breakout on D chart with $45.10 as Resistance now acting as Support. Friday was 2nd day close >$45.10. LARGE C&H TP = $88.41

0 · Reply

Merlintrader Aug. 7 at 2:50 PM

$KOD DAYBREAK Phase 3 topline data in wet AMD — expected September 2026 https://www.merlintrader.com/kodiak-sciences-stock-hub/

0 · Reply

DanFitz Aug. 7 at 12:52 AM

Here's your trade on Kodiak $KOD https://youtu.be/7jfj7zZpnSA

0 · Reply

Ecolispewy Aug. 6 at 9:33 PM

$KOD 13+ days to cover shorts out at these volumes and long conviction pushing.

0 · Reply

Ecolispewy Aug. 6 at 9:00 PM

$KOD need more volume

0 · Reply

RainyDayFund Aug. 6 at 8:58 PM

$KOD Go Baby!

0 · Reply

Stekli27 Aug. 6 at 4:32 PM

$KOD just waiting for the happy hour 🍻

0 · Reply

Cutlass Aug. 6 at 3:42 PM

$KOD Strong week unfolding, rather Perky too! ✍️👀🍒

0 · Reply

spinusn27 Aug. 6 at 3:31 PM

$KOD p

0 · Reply

droog_botski Aug. 6 at 3:25 PM

$KOD The question I have is at what price can they raise more capital ?

1 · Reply

Bretm50 Aug. 6 at 3:04 PM

$KOD SUPER

0 · Reply

Stekli27 Aug. 6 at 2:09 PM

$KOD It smells perky today.🐂

0 · Reply

Stekli27 Aug. 6 at 12:11 PM

$KOD on track 💯

1 · Reply

Stekli27 Aug. 5 at 6:54 PM

I was telling friends to buy $KOD around $1.80 almost 3 years ago, before I even had a Stocktwits account. Then I shared my thoughts on $OTLK around $0.50 before FDA approval. Now I’m saying the same about $NRSN. I think 2026 is going to change the story. The remaining dilution is much smaller than people think, and I believe the market is sleeping on the potential. Just my opinion. 😉

1 · Reply

IN0V8 Aug. 3 at 4:21 PM

$KOD Buy JP Morgan raises target price to $66 from $56

0 · Reply

Stekli27 Aug. 3 at 10:03 AM

$KOD another one 🆙

1 · Reply

Stekli27 Aug. 1 at 11:28 AM

$KOD As always, one of the best analyses I’ve read.

1 · Reply

Merlintrader Aug. 1 at 3:07 AM

$KOD Kodiak Sciences: DAYBREAK, Zenkuda and the 2026–2027 Retina Catalyst Map https://www.merlintrader.com/kodiak-sciences-stock-hub/

0 · Reply

Stekli27 Jul. 31 at 6:42 PM

$KOD Adding more. Earnings in August, readout in September. I know what I own. Let’s produce this thing and make some money. Kodiak is ready!

0 · Reply

Cutlass Jul. 30 at 8:12 PM

$KOD Solid Day ✅

0 · Reply

Stekli27 Jul. 30 at 6:27 PM

$OTLK $KOD $REGN👁️👁️

0 · Reply

BB_88_ Jul. 30 at 2:13 PM

$KOD shorted 42.39 - listen I was a buyer the other day so don’t come at me bulls - I’m just playing the chart

0 · Reply

Market Cap	2.84B
Revenue (ttm)	0.00
Net Income (ttm)	-229.97M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	511,400
Avg Vol	736,506
Day's Range	N/A - N/A
Shares Out	62.58M
Stochastic %K	83%
Beta	2.21
Analysts	Strong Sell
Price Target	$61.67